Results 11 to 20 of about 12,533 (181)
Reclaiming Pharmacovigilance: Bridging the Evidence-Practice Gap in Psychopharmacology. [PDF]
J Eval Clin PractJournal of Evaluation in Clinical Practice, Volume 32, Issue 2, March 2026.
De Las Cuevas C.
europepmc +2 more sources
Association of Atypical Antipsychotics With Lipid Abnormalities in Adult Patients With Schizophrenia: A Scoping Review. [PDF]
Neuropsychopharmacol RepThis scoping review highlights the link between atypical antipsychotics and dyslipidaemia in adults with schizophrenia, identifying clozapine and olanzapine as high‐risk agents. Biomarkers and genetic polymorphisms offer promise for personalized treatment. Further research is needed on lesser‐studied drugs and predictive tools.
Abavana V, Sadiq S.
europepmc +2 more sources
Acne caused by ziprasidone in a young patient with bipolar disorder: A case report
Frontiers in Psychiatry, 2022 BackgroundZiprasidone is a second-generation antipsychotic drug commonly used to treat schizophrenia and bipolar disorder. Acne is a common inflammatory disease of sebaceous glands in adolescents that is often co-morbid with anxiety and depression, which
Yiwen Yuan +10 more
doaj +1 more source
Drug eruption caused by ziprasidone： a case report
Sichuan jingshen weisheng, 2022 This paper reported a case of drug eruption in a male patient with first-episode schizophrenia. The patient received ziprasidone monotherapy， and experienced post-treatment remission of schizophrenic symptoms， while accompanied by drug eruption with ...
Hong Jiakun, Sun Yanbing, Liu Xiaobing
doaj +1 more source
Sensors, 2011 The construction and characterization of a new ion-selective electrode for the determination of the antipsychotic ziprasidone in mixed solvents is presented. The electrode contains a plasticized polymeric membrane based on a ziprasidone-tetraphenylborate
María Cuartero +3 more
doaj +1 more source
Frontiers in Pharmacology, 2022 Treatment-resistant schizophrenia (TRS) is a prevalent clinical problem with heterogeneous presentations. However, the clinical trial designs for new treatments are still lacking.
Hui Shi +6 more
doaj +1 more source
Application of a single-objective, hybrid genetic algorithm approach to pharmacokinetic model building. [PDF]
, 2012 A limitation in traditional stepwise population pharmacokinetic model building is the difficulty in handling interactions between model components. To address this issue, a method was previously introduced which couples NONMEM parameter estimation and ...
Belani, Chandra P +12 more
core +3 more sources
Antipsychotic switching in bipolar disorders: a systematic review. [PDF]
, 2017 With the increasingly widespread use of antipsychotics in bipolar disorder (BD), switching among these agents and between antipsychotics and mood stabilizers has become more common, in particular, since the introduction of the novel atypical ...
Bernardo Arroyo, Miquel +5 more
core +4 more sources
Restless legs syndrome following the use of ziprasidone: a case report
General Psychiatry, 2020 Restless legs syndrome (RLS) is a common sleep-related movement disorder characterised by an uncomfortable urge to move the legs that occurs during periods of inactivity.
Hui Zhou +7 more
doaj +1 more source
BMC Psychiatry, 2023 Background Ziprasidone mesylate injection is an atypical antipsychotic drug which is recently approved in China. In combination with its oral formulation, sequential therapy with ziprasidone brings new interventions to patients with agitation in the ...
Yaxue Wu +15 more
doaj +1 more source